PharmStars: A pharma-centric accelerator, enhancing digital health startups for improved patient outcomes.
Location
Boston, MA, US
Founded
2021
PharmStars is a pharma-focused accelerator dedicated to digital health startups. The program aims to drive digital health adoption and improve patient outcomes by fostering partnerships between pharmaceutical companies and innovative digital health solutions. PharmStars typically provides non-equity assistance to its portfolio companies, with occasional seed investments.
The accelerator offers cohort-based programs centered on specific themes, such as "Digital Innovations in Oncology." PharmStars' unique value proposition lies in its industry-specific focus, connecting digital health startups with pharmaceutical partners to accelerate adoption and impact. The program provides tailored support to help startups navigate the complex pharmaceutical landscape and develop solutions that address critical industry needs.
PharmStars - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies14
Current Portfolio Count14
Top Investment Stages
Pre-Seed1 (33.3%)
Seed1 (33.3%)
Series A1 (33.3%)
Stage Mix
Pre-Seed 33%Seed 33%Series A 33%
Concentration shown as share of disclosed investments by stage.
